Design of a dimeric‐nanobody specific for Aß1‐42 oligomers: the Dimeric‐DesAb‐O
Liliana Napolitano, Devkee Vadukul, Fabrizio Chiti, Cristina Cecchi, Roberta Cascella, Francesco Aprile · 2025
Read Design of a dimeric‐nanobody specific for Aß1‐42 oligomers: the Dimeric‐DesAb‐O by Liliana Napolitano, Devkee Vadukul, Fabrizio Chiti, Cristina Cecchi, Roberta Cascella, Francesco Aprile (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712790.txt.
Description
Napolitano and co-authors design in 2025 a dimeric nanobody aimed at toxic amyloid beta oligomers in Alzheimer's disease. Small soluble oligomers, not mature fibrils, are the main neurotoxic agents in the disease. An earlier single domain antibody, DesAb-O, already binds these oligomers and blocks their harm in cells.
The new design links two DesAb-O domains with a flexible linker, to raise binding strength and avidity. After expression and purification, mass and structure checks confirmed the construct. Aggregation assays and binding assays then tested whether it blocks amyloid assembly and grips the oligomers. The dimeric form is offered as a stronger tool for detection and therapy research.
Catalog record
| CREATOR | Liliana Napolitano, Devkee Vadukul, Fabrizio Chiti, Cristina Cecchi, Roberta Cascella, Francesco Aprile |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |